DSM Business Revenue Decline Due to Fewer Sales Representatives
First written in FY2017-Q3. 11 of 32 entries say "Worsened", first in FY2018-Q2. Latest entry: FY2026.
Yamano Holdings moved to the "Worse" side of this theme in 2017.
0 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「In the Life Plus business, structural challenges such as the aging of sales staff and customers continued. However, as a result of promoting sales-channel expansion, strengthening event sales and tightening cost controls, revenue increased and profitability improved significantly. These initiatives improved the business foundation and restored the business to profitability.」
Despite the continuing structural challenge of an aging sales force and customer base, the Life Plus business returned to profit through sales-channel expansion, stronger event sales and cost controls. - FY2026-H1MitigatedAnnual report
「In the Life Plus business, structural challenges such as the aging of sales staff and customers continued. However, as a result of consolidating and closing locations, expanding sales channels, strengthening event sales and tightening cost controls, profitability improved significantly and the business returned to profit for the first half.」
Despite ongoing structural challenges, including the aging of sales staff and customers, the Life Plus business returned to profit in the first half through location consolidation and closure, sales-channel expansion, stronger event sales and cost controls. - FY2025MitigatedAnnual report
「Meanwhile, in terms of earnings, fixed-cost reductions from consolidating and closing locations and further strengthening of cost management resulted in an improved segment loss of ¥31 million, compared with ¥49 million in the previous fiscal year.」
Although sales continued to decline due to the aging of sales staff and customers, consolidation and closure of locations, and lower sales-staff activity, fixed-cost reductions and stronger cost management narrowed the DSM business loss. - FY2025-H1Revenue continued to decline, but the loss narrowedAnnual report
「In the DSM business, conditions remained difficult due to the aging of sales staff and customers. Sales were also affected by the consolidation and closure of locations and lower sales-staff activity, and amounted to ¥404 million, down 7.8% year on year. In terms of earnings, fixed-cost reductions from consolidating and closing locations and further strengthening of cost management resulted in an improved segment loss of ¥19 million, compared with ¥21 million in the same period of the previous year.」
Although sales continued to decline due to the aging of sales staff and customers, consolidation and closure of locations, and lower sales-staff activity, fixed-cost reductions and stronger cost management narrowed the segment loss from ¥21 million to ¥19 million. - FY2024-Q3WorsenedAnnual report
「In the DSM business, conditions remained difficult partly due to the aging of sales staff and customers, but the decline in revenue narrowed as the Company worked to strengthen its management foundation. Sales were also affected by the consolidation and closure of locations in the previous fiscal year and lower sales-staff activity, and amounted to ¥655 million, down 7.7% year on year. Although the Company continued to strengthen cost management, the decline in gross profit due to lower sales could not be offset, and the segment loss was ¥35 million, compared with a loss of ¥4 million in the same period of the previous year.」
Amid continuing aging of sales staff and customers, consolidation and closure of locations, and lower sales-staff activity, sales fell 7.7% year on year and the segment loss widened from ¥4 million to ¥35 million. - FY2024-Q2The rate of revenue decline narrowed, but aging and the loss widenedAnnual report
「In the DSM business, conditions remained difficult partly due to the aging of sales staff and customers, but the decline in revenue narrowed as the Company worked to strengthen its management foundation. Sales were also affected by the consolidation and closure of locations in the previous fiscal year and lower sales-staff activity, and amounted to ¥439 million, down 7.2% year on year. Although the Company continued to strengthen cost management, the decline in gross profit due to lower sales could not be offset, and the segment loss was ¥21 million, compared with a loss of ¥1 million in the same period of the previous year.」
While the aging of sales staff and customers and lower sales-staff activity continued, the decline in revenue was said to be narrowing. Sales fell 7.2% year on year, and the segment loss widened from ¥1 million to ¥21 million. - FY2024-Q1WorsenedAnnual report
「In the DSM business, conditions remained difficult, and sales were affected by the consolidation and closure of locations in the previous fiscal year and lower sales-staff activity. Sales amounted to ¥208 million, down 8.3% year on year. Although the Company continued to strengthen cost management, the decline in gross profit due to lower sales could not be offset, and the segment loss was ¥18 million, compared with a loss of ¥7 million in the same period of the previous year.」
The impact of consolidating and closing locations and lower sales-staff activity continued, and DSM business sales fell 8.3% year on year. Although cost management continued, the segment loss widened from ¥7 million to ¥18 million. - FY2023-Q3MitigatedAnnual report
「In the DSM business, conditions remained difficult even after restrictions on activity related to the COVID-19 pandemic were lifted, and sales were also affected by the reduction in the number of locations. Sales amounted to ¥709 million, down 2.2% year on year. Meanwhile, stronger cost management and the closure of unprofitable locations helped improve the segment loss to ¥4 million from ¥19 million in the same period of the previous year.」
DSM business sales continued to decline due to the reduction in the number of locations and other factors, while stronger cost management and the closure of unprofitable locations narrowed the segment loss from ¥19 million to ¥4 million. - FY2023-Q2MitigatedAnnual report
「In the DSM business, conditions remained difficult even after restrictions on activity related to the COVID-19 pandemic were lifted. However, efforts to increase sales at product demonstration sales events through a stronger staffing structure resulted in sales of ¥473 million, up 2.0% year on year, and an improved segment loss of ¥1 million, compared with ¥21 million in the same period of the previous year.」
Although conditions remained difficult, stronger staffing resulted in a 2.0% year-on-year increase in sales, and the segment loss narrowed from ¥21 million to ¥1 million. - FY2023-Q1MitigatedAnnual report
「Although sales from direct sales declined due to lower sales-staff activity, sales amounted to ¥227 million, up 0.8% year on year, and the segment loss improved to ¥7 million from ¥18 million in the same period of the previous year.」
Although the decline in direct-sales revenue due to lower sales-staff activity remained, DSM business sales increased year on year and the segment loss narrowed from ¥18 million to ¥7 million. - FY2022The rate of revenue decline and the loss both narrowedAnnual report
「In the DSM business, attracting customers to product demonstration sales events remained difficult. The Company promoted sales of health-related products for which demand rose during the COVID-19 pandemic and worked to strengthen direct sales, but sales were affected by the consolidation and closure of business locations and lower sales-staff activity. Sales amounted to ¥968 million, down 8.4% from the previous fiscal year. Meanwhile, the Company strengthened cost management, improving the segment loss to ¥22 million from ¥33 million in the previous fiscal year.」
Although sales continued to decline due to difficulty attracting customers to product demonstration sales events and the consolidation and closure of business locations, the rate of decline was 8.4% and the segment loss narrowed from ¥33 million to ¥22 million. - FY2022-Q3The rate of revenue decline and the loss both narrowedAnnual report
「In the DSM business, attracting customers to product demonstration sales events remained difficult. The Company promoted sales of health-related products for which demand rose during the COVID-19 pandemic and worked to strengthen direct sales, but sales were affected by the consolidation and closure of business locations and lower sales-staff activity. Sales amounted to ¥725 million, down 8.7% year on year. Meanwhile, the Company strengthened cost management, improving the segment loss to ¥19 million from ¥32 million in the same period of the previous year.」
Sales continued to decline due to difficulty attracting customers to product demonstration sales events and the consolidation and closure of business locations, while the rate of decline was 8.7% and the segment loss narrowed from ¥32 million to ¥19 million. - FY2022-Q2The rate of revenue decline and the loss both narrowedAnnual report
「As a result, partly due to the impact of consolidating and closing business locations, sales amounted to ¥464 million, down 10.0% year on year. However, the segment loss improved slightly to ¥21 million, compared with a loss of ¥27 million in the same period of the previous year.」
In the DSM business, consolidation and closure of business locations and difficulty attracting customers to product demonstration sales events continued, while sales fell 10.0% year on year and the segment loss narrowed from ¥27 million to ¥21 million. - FY2022-Q1Revenue was broadly flat, and the loss narrowedAnnual report
「In the DSM business, we promoted sales of health-related products, for which demand had increased from the previous fiscal year, and worked to strengthen door-to-door sales. However, the prolonged impact of COVID-19 made attracting visitors to sales exhibitions persistently difficult. As a result, partly due to the consolidation of business locations, revenue was ¥225 million, down 0.5% year on year. At the same time, we reviewed sales costs and worked to strengthen cost controls, improving the segment loss to ¥18 million from a segment loss of ¥39 million in the same period of the previous year.」
Although difficulty attracting customers to product demonstration sales events and the impact of consolidating and closing business locations continued, the sales decline was limited to 0.5% year on year due to a review of sales costs and other measures, and the segment loss narrowed. - FY2021The rate of revenue decline widened, but the loss narrowedAnnual report
「The Company worked to strengthen direct sales, increased sales of sewing machines and air purifiers, for which demand rose as people refrained from going out, and promoted the rebuilding of trust with customers, the reactivation of dormant customers and the development of new customers. However, partly due to the consolidation and closure of business locations, sales amounted to ¥1,057 million, down 24.9% from the previous fiscal year, and the segment loss was ¥33 million, compared with a loss of ¥53 million in the previous fiscal year.」
In the DSM business, the sales decline widened to 24.9% from the previous fiscal year, while sales of sewing machines and air purifiers, customer development and strengthened direct sales narrowed the segment loss from ¥53 million to ¥33 million. - FY2021-Q3The rate of revenue decline narrowed, but the loss widenedAnnual report
「In the DSM business, the Company increased sales of sewing machines and air purifiers, for which demand rose as people refrained from going out, and promoted the reactivation of dormant customers and development of new customers. However, sales were affected by repeated cancellations of product demonstration sales events due to the spread of COVID-19. Sales amounted to ¥794 million, down 27.3% year on year, and the segment recorded a loss of ¥32 million, compared with a loss of ¥30 million in the same period of the previous year.」
Although the Company promoted sales of new products and customer development, sales fell 27.3% due to the impact of canceled product demonstration sales events, and the segment loss widened from ¥30 million in the same period of the previous year to ¥32 million. - FY2021-Q2WorsenedAnnual report
「In the DSM business, sales were affected by a succession of cancellations and postponements of product demonstration sales events due to the spread of COVID-19. Sales amounted to ¥515 million, down 31.5% year on year, and the segment recorded a loss of ¥27 million, compared with a loss of ¥15 million in the same period of the previous year.」
Cancellations and postponements of product demonstration sales events caused DSM business sales to fall 31.5% year on year, while the segment loss widened from ¥15 million to ¥27 million. - FY2021-Q1WorsenedAnnual report
「In the DSM business, sales were affected by a succession of cancellations and postponements of product demonstration sales events due to the spread of COVID-19. Sales amounted to ¥226 million, down 34.0% year on year, and the segment recorded a loss of ¥39 million, compared with a loss of ¥21 million in the same period of the previous year.」
Cancellations and postponements of product demonstration sales events caused DSM business sales to fall 34.0% year on year, while the segment loss widened from ¥21 million to ¥39 million. - FY2020-Q3WorsenedAnnual report
「In the DSM business, the Company substantially reviewed its business management and operating structure from the second quarter, but acquiring new customers and reinforcing the sales staff remained difficult. The number of business locations also declined by 8 year on year, and sales amounted to ¥1,093 million, down 15.1% year on year, while the segment recorded a loss of ¥30 million, compared with segment profit of ¥0 million in the same period of the previous year.」
Difficulty acquiring new customers and reinforcing the sales staff and the decline in the number of business locations continued. DSM business sales fell 15.1% year on year, and the segment loss was ¥30 million. - FY2020-Q2RestatedAnnual report
「In the DSM business, the Company substantially reviewed its business management and operating structure from the second quarter, resulting in some recovery in earnings. However, acquiring new customers and reinforcing the sales staff remained difficult. The number of business locations also declined by 8 year on year, and sales amounted to ¥752 million, down 13.3% year on year, while the segment recorded a loss of ¥15 million, compared with segment profit of ¥0 million in the same period of the previous year.」
Difficulty acquiring new customers and reinforcing the sales staff and the decline in the number of business locations continued. Sales fell 13.3% year on year, and the segment recorded a loss of ¥15 million. - FY2020-Q1WorsenedAnnual report
「In the DSM business, conditions remained difficult, with little progress in acquiring new customers or reinforcing the sales staff. As the number of business locations decreased by 6 year on year, sales amounted to ¥343 million, down 15.6% year on year, and the segment recorded a loss of ¥21 million, compared with a loss of ¥12 million in the same period of the previous year.」
Amid continuing difficulty acquiring new customers and reinforcing the sales staff, sales fell 15.6% year on year and the segment loss widened from ¥12 million to ¥21 million. - FY2019Revenue continued to decline, but the loss was eliminatedAnnual report
「As a result, sales amounted to ¥1,706 million, down 14.3% from the previous fiscal year. However, partly because the Company worked to reduce operating costs, segment profit was ¥0 million, compared with a segment loss of ¥22 million in the previous fiscal year, eliminating the loss.」
Although difficulty acquiring new customers and reinforcing the sales staff and declining sales continued, the segment loss was eliminated through operating cost reductions. - FY2019-Q3WorsenedAnnual report
「As a result, sales amounted to ¥1,287 million, down 16.4% year on year, and segment profit was ¥0 million, down 76.7% year on year.」
Amid continuing difficulty reinforcing the sales staff and acquiring new customers, DSM business sales fell 16.4% year on year and segment profit was ¥0 million, indicating a continuing impact on earnings. - FY2019-Q2RestatedAnnual report
「Although the Company is urgently working to develop new products and transform its sales channels in the DSM business, acquiring new customers and reinforcing its sales staff remain difficult. It consolidated and closed 7 business locations during the first half. As a result, sales amounted to ¥868 million, down 17.9% year on year, and segment profit was ¥0 million, down 98.1% year on year.」
Difficulty securing new customers and sales staff and the reduction in business locations continued. Sales fell 17.9% year on year, and segment profit was ¥0 million. - FY2019-Q1WorsenedAnnual report
「Although the Company is urgently working to develop new products and transform its sales channels in the DSM business, acquiring new customers and reinforcing its sales staff remain difficult. It consolidated and closed 7 business locations during the current quarter. As a result, sales amounted to ¥406 million, down 20.7% year on year, and the segment recorded a loss of ¥12 million, compared with segment profit of ¥5 million in the same period of the previous year.」
Amid continuing difficulty securing new customers and sales staff, the Company consolidated and closed 7 business locations. Sales fell 20.7% year on year, and the segment recorded a loss of ¥12 million. - FY2018WorsenedAnnual report
「In the DSM business, the sales format itself, direct sales, is becoming ill-suited to the times as mail-order sales and other channels become more widespread. As a result, the Company has faced difficulty acquiring new customers and reinforcing its sales staff, and sales have continued to decline.」
The Company disclosed the structural obsolescence of the DSM business sales format, difficulty securing new customers and sales staff, and continuing revenue declines. In the current fiscal year, sales fell 15.8% year on year and the segment recorded a loss of ¥22 million. - FY2018-Q3WorsenedAnnual report
「The Company consolidated and closed 6 business locations in the previous fiscal year and 3 during the current quarter, resulting in sales of ¥1,539 million, down 13.7% year on year.」
In the DSM business, consolidation and closure progressed to 3 locations during the current quarter, while the rate of sales decline reached 13.7% year on year, indicating a further decline in sales associated with the reduction in sales bases. - FY2018-Q2WorsenedAnnual report
「The Company consolidated and closed 6 business locations in the previous fiscal year and 1 during the current quarter, resulting in sales of ¥1,056 million, down 12.5% year on year.」
In the DSM business, the consolidation and closure of business locations progressed by 1 location during the current quarter, while sales fell 12.5% year on year, making the decline associated with the reduction in sales bases more pronounced in the figures. - FY2017MaterialisedAnnual report
「The Company consolidated and closed business locations, reducing its sales bases by 6. As a result of the decrease in sales staff and other factors, sales amounted to ¥2,363 million, down 8.9% year on year, and」
The decrease in sales bases and sales staff materialized as an 8.9% year-on-year decline in DSM business sales. - FY2017-Q3First statedAnnual report
「In the DSM business, the number of stores as of 31 December 2016 was 72, down 2 from 74 in the same quarter of the previous year, and sales declined due to a decrease in sales staff.」
For the first time, a decrease in sales staff was explicitly identified, together with the decrease in the number of stores, as a factor behind the decline in DSM business sales, which fell 7.8% year on year.